Elsevier Science Ltd.

SHERPA: Unknown

People

  1. Boelens
    Boelens
  2. O'Reilly
    O'Reilly
  3. Curran
    Curran
  4. Mcavoy
    Mcavoy
  5. Cancio
    Cancio
  6. Oved
    Oved
  7. Mauguen
    Mauguen
  8. Scaradavou
    Scaradavou
  9. Troullioud Lucas
    Troullioud Lucas
  10. Maryamchik
    Maryamchik

Groups

  1. Pediatrics, Department of (43)
  2. Stem Cell Transplantation and Cellular Therapy Service (43)
  3. Tow Center for Developmental Oncology (TCDO) (41)
  4. Department of Medicine (38)
  5. GSK Faculty (24)
  6. Center for Hematologic Malignancies (22)
  7. Hematologic Malignancies, Division of (22)
  8. Sloan Kettering Institute Faculty (20)
  9. Immunology Program Faculty (16)
  10. Adult Leukemia (11)
Search Within
Formats
  1. Meeting Abstract (34)
  2. Journal Article (28)
  3. Review (8)
  4. Guidelines (3)
  5. Book Section (1)
Groups
  1. Pediatrics, Department of (43)
  2. Stem Cell Transplantation and Cellular Therapy Service (43)
  3. Tow Center for Developmental Oncology (TCDO) (41)
  4. Department of Medicine (38)
  5. GSK Faculty (24)
  6. Center for Hematologic Malignancies (22)

More Groups

People
  1. Jaap Jan Boelens (34)
  2. Richard O'Reilly (12)
  3. Susan Prockop (10)
  4. Devin Mcavoy (9)
  5. Elizabeth Klein (9)
  6. Kevin Curran (9)

More People

Years
  1. 2025 (9)
  2. 2024 (8)
  3. 2023 (6)
  4. 2022 (10)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Cytotherapy (73)
  2. Encyclopedia of Creativity. 3rd ed (1)

Results (74)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; A tri-institutional analysis
    Journal Article

    Troullioud Lucas, A. G.; Lindemans, C. A.; Bhoopalan, S. V.; Dandis, R.; Prockop, S. E.; Naik, S.; Keerthi, D.; de Koning, C.; Sharma, A.; Nierkens, S.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant
    Review

    Garcia-Rosa, M.; Abraham, A.; Bertaina, A.; Bhoopalan, S. V.; Bonfim, C.; Cohen, S.; DeZern, A.; Louis, C.; Oved, J.; Pavel-Dinu, M.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Transplant for non-malignant disorders: An International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering
    Guidelines

    Klein, O. R.; Bonfim, C.; Abraham, A.; Ruggeri, A.; Purtill, D.; Cohen, S.; Wynn, R.; Russell, A.; Sharma, A.; Ciccocioppo, R.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients
    Journal Article

    Camacho-Bydume, C.; Mauguen, A.; Rodriguez-Sanchez, M. I.; Klein, E.; Kernan, N. A.; Prockop, S.; Boelens, J. J.; Papanicolaou, G. A.; Cancio, M.
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Viral infection in hematopoietic stem cell transplantation: An International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment
    Review

    Stanojevic, M.; Bertaina, A.; Bonfim, C.; Ciccocioppo, R.; Cohen, S.; Purtill, D.; Ruggeri, A.; Russell, A.; Sharma, A.; Wynn, R.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Considerations for immune effector cell therapy collections: A white paper from the American Society for Apheresis
    Journal Article

    Liu, H. D.; Su, L.; Winters, J. L.; Thibodeaux, S. R.; Park, Y. A.; Wu, Y.; Schwartz, J.; Zubair, A. C.; Schneiderman, J.; Gupta, G. K.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Autologous car T cell product from COVID-19-positive patient: Manufacturing and regulatory considerations
    Meeting Abstract

    Sikder, D.; Senechal, B.; Wang, X.; Geyer, M.; Riviere, I.
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Early CD4 T cell immune reconstitution after HCT is associated with reduced non- relapse related mortality but not with decreased relapse risk
    Meeting Abstract

    Troullioud Lucas, A.; Sharma, A.; de Koning, C.; Bhoopalan, S.; Keerthi, D.; Prockop, S.; Nierkens, S.; Lindemans, C.; Boelens, J. J.
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Imaging cellular therapeutics in vivo for safety and efficacy: Perspectives and a new resource from the multi-stakeholder committee HESI CT-TRACS
    Meeting Abstract

    Mouries, L. P.; Chen, C. L.; Helfer, B.; Ponomarev, V.; Patrick, P.; Thu, M. S.; van den Hoorn, T.; Shingleton, W. D.
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Discovery proteomics for analytes to predict cytokine release syndrome on day of infusion of chimeric antigen receptor (CAR) T cells
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; Mcavoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save

    • Elsevier Science Ltd. – authorized name for: